Menu
Back to Journals » OncoTargets and Therapy » Volume 12
Original Research
BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,561 | Dovepress* | 4,272+ | 658 | 4,930 | |
| PubMed Central* | 289 | 121 | 410 | ||
| Totals | 4,561 | 779 | 5,340 | ||
| *Since 28 August 2019 | |||||
View citations on PubMed Central and Google Scholar